Search
forResearch 10 of 716
- Defolliculated (Dfl): A Dominant Mouse Mutation Leading to Poor Sebaceous Gland Differentiation and Total Elimination of Pelage Follicles
- Immunohistochemical and autoradiographic findings suggest that minoxidil is not localized in specific cells of vibrissa, pelage, or scalp follicles
- Ficoll density gradient sedimentation isolation of pelage hair follicle mesenchymal stem cells from adult mouse back skin: a novel method for hair follicle mesenchymal stem cells isolation
- Ficoll density gradient sedimentation isolation of pelage hair follicle mesenchymal stem cells from adult mouse back skin: A novel methods for hair follicle mesenchymal stem cells isolation.
- Control of pelage hair follicle development and cycling by complex interactions between follistatin and activin
- An optimized force-triggered density gradient sedimentation method for isolation of pelage follicle dermal papilla cells from neonatal mouse skin
- Expression of Cyclooxygenase Isozymes During Morphogenesis and Cycling of Pelage Hair Follicles in Mouse Skin: Precocious Onset of the First Catagen Phase and Alopecia upon Cyclooxygenase-2 Overexpression
- Properties of Murine Pelage Hair Follicles in Monolayer and Collagen Matrix Cultures
- Effects of <i>in utero</i> retinoic acid exposure on mouse pelage hair follicle development
- Hair follicle associated pluripotent (HAP) stem cells jump from transplanted whiskers to pelage follicles and stimulate hair growth
Community 10 of 61
- New Study: PP405, developed by Pelage Pharmaceuticals, can reactivate dormant hair follicle stem cells and stimulate natural hair growth by 20%
- Pelage Pharmaceuticals’ PP405 and its Impact on Follicular Regeneration to be Presented at the American Academy of Dermatology (AAD) Annual Meeting 2026
- Pelage PP405: New Hair Growth from Inactive Follicular Units - Phase 2a results at AAD 2026
- Pelage have made a new post about PP405
- Everything you ever wanted to know about Pelage Pharma's PP405: how it works and what to expect
- Pelage Pharmaceuticals’ PP405 and its Impact on Follicular Regeneration to be Presented at the American Academy of Dermatology (AAD) Annual Meeting 2026 28th march
- Pelage, PP405, is creating a database for potential new trial volunteers
- I think we should all keep an eye out for Pelage PP405. February 2025 will be interesting.
- Quote from Pelage (PP-405) Spokesperson...
- Phase 2B trial for PP405 leaked (The study Pelage DOESN'T want you to see)